-+ 0.00%
-+ 0.00%
-+ 0.00%

ABIVAX SA: REMAINS ON TRACK TO SUBMIT FIRST NDA FOR OBEFAZIMOD FOR TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS BY END OF 2026

Reuters·07/30/2026 20:05:07

Please log in to view news